Shulman, D G <br/><br/>
A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.  [electronic resource] 

 -  Ophthalmology  Feb 1999 
 - 362-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0161-6420 
<br/><br/><label>Standard No.: </label>10.1016/S0161-6420(99)90077-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Androstadienes--administration & dosage<br/>Anti-Allergic Agents--administration & dosage<br/>Anti-Inflammatory Agents--administration & dosage<br/>Conjunctivitis, Allergic--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Intraocular Pressure--drug effects<br/>Loteprednol Etabonate<br/>Male<br/>Middle Aged<br/>Ophthalmic Solutions--administration & dosage<br/>Prospective Studies<br/>Safety<br/>Seasons<br/>Treatment Outcome